Navigation Links
FDAnews Announces — Data Integrity in Clinical Trials Webinar, March 22, 2016

Data Integrity in Clinical Trials
March 22, 2016 — 1:30 p.m. – 3:00 p.m. EDT

Let’s face it. There’s more pressure than ever to conduct more complex and larger trials and to do them faster.

This webinar will provide invaluable guidance on how to keep the focus on data collection and integrity, with specific lessons that make data integrity even better and more compliant. Here are the areas of focus for this practical, no-holds-barred webinar:

Common BIMO Inspections Findings:

  •     Failure to follow investigational plan and/or regulations
  •     Protocol deviations
  •     Inadequate recordkeeping
  •     Inadequate accountability for the investigational product
  •     Inadequate communication with the IRB
  •     Inadequate subject protection — failure to report AEs and informed consent issues
  •     Inadequate monitoring
  •     Failure to bring investigators into compliance
  •     Inadequate accountability for the investigational product
  •     Failure to obtain FDA and/or IRB approval prior to study initiation

Violations Leading To Approval Delay or Complete Response Letter:

  •     Sponsor/CRO: Data entry quality control
  •     Sponsor/CRO: Database changes after initial database lock and study unblinding
  •     Investigators: Systemic deficiencies, including the persistence of critical errors across study sites that raise questions about the reliability of data at other, non-inspected sites and sponsor oversight, such as:

–    Enrollment of subjects who violate eligibility criteria
–    Inaccurate administration of the test product
–    Omission of procedures critical to interpret study endpoint

Prevent and Identify Potential Clinical Data Integrity Issues

  •     Real diligence in selecting and engaging involving;

–    Clinical investigators and sites
–    Site monitors
–    Clinical research organizations
–    Internal or external parties responsible for database management

  •     Real risk-based site and data monitoring (not less monitoring)
  •     Audits

–    Who and what data will be audited, who sees results, who is accountable for decision-making?

  •     Who is responsible for remediation, including GCP “CAPA”
  •     Quality by Design

Remediation Strategies and Corrective Actions

  •     How to develop a remediation plan that meets all the criteria for compliance
  •     How to prioritize remediation by risk:

–    Immediate risk to human subject safety and welfare, breach of eligibility, failure to administer test product per protocol, failure to conduct evaluations critical to major efficacy and safety endpoints (including under-reporting of adverse events)
–    Data falsification issues

  •     How to directly communicate with the clinical investigator and not just the study coordinator
  •     How to, as a sponsor, ensure the prompt securing of compliance

Register today to get ready to develop and maintain data integrity during clinical trials.

Meet the Presenter:
Dr. Beverly Lorell, Senior Medical and Policy Advisor, FDA & Life Sciences Practice Group, King & Spalding
Beverly Lorell is the senior medical and policy advisor with the firm’s FDA & Life Sciences Practice Group in Washington, D.C. She specializes in the clinical trial design for drug, device and biologics studies; review of pre-market submissions; recalls; and assessment of matters involving a risk to health. She also specializes in physician and industry relations and develops independent scientific panels to advise health industries.

Who Will Benefit:

  •     Medical Affairs Officers
  •     Director of Clinical Operations
  •     Regulatory Affairs Professionals
  •     Director of Publications
  •     Director of Clinical Trial Regulatory Management
  •     Clinical Trial Information Disclosure Directors
  •     Global Clinical Safety and Pharmacovigilance Officers

Webinar Details:
Data Integrity in Clinical Trials
March 22, 2016 — 1:30 p.m. – 3:00 p.m. EDT

$287 per site

Easy Ways to Register:
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDAnews Announces — First Cycle Approval of ANDAs: The Journey from Conception to Reality Webinar, March 23, 2016
2. FDAnews Announces — Pharma Strategies in Latin America: Keys to Success Special Two-Part FDAnews Webinar, March 15 and April 5, 2016
3. FDAnews Announces: Building a World-Class Advertising and Promotion Review Program Workshop, April 27-28, 2016
4. FDAnews Announces: Medical Device Risk Management: Developing the Total Program, March 24-25, Arlington, VA
5. FDAnews Announces — FDA’s New Guidance on Emerging Technology Applications: What it Really Means for Pharmaceutical Companies Webinar, March 10, 2016
6. FDAnews Announces — CDRH Enforcement Trends: Back to the Future Webinar, Feb. 25, 2016
7. FDAnews Announces — Fixed Dose Combination Drug Development: What’s in Store? Webinar, Feb. 29, 2016
8. FDAnews Announces — Leveraging Social Media in Pharma:The Hidden Message from the Masses Webinar, Feb. 16, 2016
9. FDAnews Announces — Developing Innovative Approaches to Postmarketing Safety Data Collection in Pregnant Women Webinar, Feb. 24, 2016
10. FDAnews Announces: 13th Annual Medical Device Quality Congress: Building a Culture to Succeed, March 15-17, 2016, Rockville, MD
11. FDAnews Announces — FDA’s New Device De Novo Reclassification Webinar, Feb. 9, 2016
Post Your Comments:
(Date:5/30/2020)... Okla. (PRWEB) , ... May 29, 2020 , ... In ... community, now more than ever, James Hodge Hyundai is offering a $500 bonus towards ... take advantage of this incentive now through January 4, 2021. , To qualify for ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... an important new 7th Donor Shield protection. Donors can now be reimbursed for ... Donor Shield program. The other six Donor Shield protections include lost wage reimbursement ...
(Date:5/27/2020)... FOWLERVILLE, Mich. (PRWEB) , ... May 27, 2020 , ... ... the Covid-19 curve and Howell Michigan, Fowlerville Michigan , and Ann Arbor Michigan. ... by seeing all high-risk patients within the clinic and at the hospital. We have ...
(Date:5/26/2020)... WASHINGTON (PRWEB) , ... May ... ... discovered a previously unknown mechanism through which certain infections can impact the ... PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric ...
(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, and ... Joan Price have just received the 2020 AASECT Audio Visual Award for jessica drake's ... the first of its kind to feature non-actors in its demonstrations and narratives and ...
Breaking Medicine News(10 mins):
(Date:5/30/2020)... ... May 29, 2020 , ... United Nations Foundation ... U.S. announcement that it will terminate its relationship with the World Health Organization ... to terminate its relationship with the World Health Organization. Any move of this ...
(Date:5/30/2020)... ... May 30, 2020 , ... During a crisis, the platitude “stay strong” is ... it is developed and strengthened through hardship. Recent research conducted by ... certain practices in order to stay strong in the face of adversity. It seems ...
(Date:5/28/2020)... ... May 28, 2020 , ... When Sean Fitzgerald was in business ... able to help provide the physical care services needed to keep older adults in ... houses themselves. Now Fitzgerald is pleased to be in a position to help provide ...
Breaking Medicine Technology: